Pentagon temporarily halts new testosterone‑deficiency screening guidance for troops

The Pentagon has announced a temporary suspension of the clinical guidance that would have required mandatory testosterone deficiency screening for service members aged 30 and older. The decision reverses a policy that was recently issued, halting its implementation while further review is conducted.

According to a U.S. official, the guidance was intended to identify testosterone deficiency among eligible personnel, but the department has now opted to pause the rollout. No specific timeline has been provided for when, or if, the guidance might be reinstated.

The original policy would have mandated that all eligible service members undergo testing to detect low testosterone levels, a condition that can affect health and performance. The temporary rescindment means that the screening will not be carried out under the previously announced requirements.

The Pentagon did not elaborate on the reasons for the reversal, stating only that the guidance is being withdrawn on a temporary basis. Officials indicated that the decision allows for additional assessment of the policy’s implications and any necessary adjustments.

The move affects all branches of the U.S. armed forces, and service members who were preparing for the screening are now advised to await further instructions from their respective commands.